Category Archives: Interventional Cardiology

Morton Kern, MD, of VA Long Beach Healthcare System and University of California, Irvine, often engages his colleagues via email in brief, informal dialogue on clinically relevant topics in interventional cardiology. With permission from the participants, TCTMD presents their conversations for the benefit of the cardiology community. Your feedback is welcomefeel free to comment at the bottom of the page Continue reading →

The Global Interventional Cardiology Market report covers important aspects of this market concerning fundamental parameters. The report explains outline of the business range, concentrating on the overall industry, development possibilities, types and application Continue reading →

Global Pediatric Interventional Cardiology Devices Market 2020 research affords a number one review of the business enterprise inclusive of characterizations, companies, displays and organisation chain shape. The evaluation is recommended with Pediatric Interventional Cardiology Devices market trends research, evaluation additionally covers each the winning and earlier cutting-edge market developments, drivers and barriers faced through Pediatric Interventional Cardiology Devices Market Continue reading →

Shares of ABIOMED, Inc. (NASDAQ:ABMD) have received an average rating of Hold from the eleven research firms that are covering the firm, MarketBeat reports Continue reading →

Global Interventional Cardiology and Peripheral Vascular Devices Market 2020 report is the comprehensive study of current and future market analysis, trends & growth factors. This report also elaborates Interventional Cardiology and Peripheral Vascular Devices market size, consumer volume, share, demand and supply status. In addition, factors affecting the growth of Interventional Cardiology and Peripheral Vascular Devices market and future trends that will boom in the market. Continue reading →

WAYNE, Pa., Dec. 30, 2019 (GLOBE NEWSWIRE) -- Liam Kelly, President and CEO, Teleflex Incorporated (TFX), is scheduled to speak at the Goldman Sachs 12th Annual Healthcare CEOs Unscripted: A View from the Top conference at the Goldman Sachs Office in New York, NY, on Thursday, January 9, 2020 at 2:50 p.m Continue reading →

Transparency Market Research, in its latest market intelligence study, finds that the global Pediatric Interventional Cardiology market registered a value of ~US$ xx Mn/Bn in 2018 and is spectated to grow at CAGR of xx% during the foreseeable period 2019-2029. In terms of product type, segment holds the largest share, while segment 1 and segment 2 hold significant share in terms of end use. Continue reading →

Another year in the books, and there were some important news stories in cardiology this year. 2019 carried big news for a few drug therapies, and one study early in the year gave an initial serious look at the potential of wearable technology to have an impact in cardiac care. Continue reading →

Global Probiotics Market: Overview Probiotics are the small micro-organisms originated through yeast and bacteria that benefit human and animals by maintaining intestinal microbial balance. These probiotics ingredients stimulate enzymes and natural digestive juices to maintain proper functioning of the digestive system and are administered through supplements or processed food. Probiotics help in strengthening the human immune system reduce body pathogens and protect proteins and lipids from oxidative destruction Continue reading →

Market share of global Interventional Cardiology and Peripheral Vascular Device industry is dominate by companies like Abbott Laboratories, Boston Scientific, C. R Continue reading →